One person found a $6.99 TJ Maxx teapot retailing for $7.37 at Goodwill and another reported on a $6 Target purse priced at ...

Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in ...

Chevron's strategic moves and positive developments position the company for growth and success, making it a strong choice ...

Alarm bells over Democratic vice presidential candidate Tim Walz’s deep ties to China are stirring debate on national ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

Brokerage firms have given a mixed reaction to the shares of drug maker CIPLA Ltd. The pharma company announced its results ...

QIAGEN is expanding its portfolio for QIAstat-Dx in North America, with the recent launch of the QIAstat-Dx Analyzer 2.0, FDA clearance of the Gastrointestinal Panel 2 and submission for FDA clearance ...

Delays in cargo clearance disrupt the flow of goods, increase costs, and undermine the country’s competitiveness in global trade. These delays impose substantial economic costs that adversely affect ...

Cipla share price had fallen after the company's September quarter results as analysts cut their target price, citing weaker than expected domestic business and challenges in its key products.

The clearance of Cipla's Goa facility opens the doors for the launch of Abraxane, which could be a around $120 million opportunity at peak.